Researchers have identified a promising new speech biomarker that could significantly enrich clinical trials by reducing sample size requirements and enhancing statistical outcomes. By using speech ...

Researchers have identified a promising new speech biomarker that could significantly enrich clinical trials by reducing ...

FDA acknowledged that AURORA and BEACON provided sufficient evidence that bitopertin significantly lowers PPIX and that there is a strong ...

By Dr. Priyom Bose, Ph.D. An examination of user reviews finds that people continue off-label Ozempic when it delivers ...

Adults living in rural communities often travel long distances when seeking treatment for cancer, but distant travel may not ...

A page may soon turn on how mental health professionals diagnose certain disorders.

FDA acknowledged that AURORA and BEACON provided sufficient evidence that bitopertin significantly lowers PPIX and that there is a strong mechanistic and biological plausibility supporting the use of ...

An orthopedic surgeon breaks down the cause of the injury and why we seem to only see it in baseball players ...

Adults living with idiopathic hypersomnia and narcolepsy type 1 often report cognitive difficulties, including problems with memory, attention, and mental fatigue. However, new research published in ...

The project focuses on increasing the diversity of genetic data and improving outcomes of conditions such as hypertension, diabetes, and triple-negative breast cancer.

Guggenheim Securities Emerging Outlook: Biotech Summit 2026 February 12, 2026 12:30 PM ESTCompany ParticipantsR.